AMN - AMN Healthcare Services, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Dallas,
United States
Type: Equity
AMN price evolution
AMN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $119.79 | $122.47 | $101.78 | |
| Short term investments | ||||
| Net receivables | $528.58 | $590.21 | $676.16 | $741.19 |
| Inventory | ||||
| Total current assets | $612.27 | $704.76 | $790.75 | $841.68 |
| Long term investments | ||||
| Property, plant & equipment | $230.59 | $197.06 | $194.54 | $191.38 |
| Goodwill & intangible assets | $1540.81 | $1564.01 | $1585.68 | |
| Total noncurrent assets | $2066.57 | $2082.85 | $2082.71 | |
| Total investments | ||||
| Total assets | $2667.82 | $2771.33 | $2873.6 | $2924.39 |
| Current liabilities | ||||
| Accounts payable | $44.03 | $283.18 | $316.02 | $343.85 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $518.55 | $573.89 | $623.9 | $656.12 |
| Long term debt | $1130.58 | $1190.28 | $1269.98 | $1304.69 |
| Total noncurrent liabilities | $1320.58 | $1395.5 | $1437.02 | |
| Total debt | $1190.28 | $1269.98 | $1304.69 | |
| Total liabilities | $1777.15 | $1894.47 | $2019.41 | $2093.14 |
| Shareholders' equity | ||||
| Retained earnings | $1492.23 | $1485.24 | $1469 | $1451.67 |
| Other shareholder equity | -$0.06 | -$0.16 | -$0.34 | -$0.42 |
| Total shareholder equity | $876.86 | $854.19 | $831.26 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $101.78 | $125.74 | $245.41 | $90.56 |
| Short term investments | ||||
| Net receivables | $741.19 | $953.25 | $1028.85 | $450.08 |
| Inventory | ||||
| Total current assets | $841.68 | $1093.64 | $1349.07 | $533.74 |
| Long term investments | ||||
| Property, plant & equipment | $191.38 | $165.54 | $154.88 | $193.91 |
| Goodwill & intangible assets | $1585.68 | $1412.2 | $1406.8 | $1429.4 |
| Total noncurrent assets | $2082.71 | $1794.71 | $1782.84 | $1819.77 |
| Total investments | ||||
| Total assets | $2924.39 | $2888.35 | $3131.91 | $2353.51 |
| Current liabilities | ||||
| Accounts payable | $343.85 | $78.06 | $425.26 | $167.88 |
| Deferred revenue | $11.82 | $15.95 | $11 | |
| Short long term debt | $8.09 | $11.38 | $19.72 | |
| Total current liabilities | $656.12 | $857.93 | $969.39 | $422.96 |
| Long term debt | $1304.69 | $843.5 | $855.69 | $935.76 |
| Total noncurrent liabilities | $1437.02 | $986.78 | $1000.49 | $1110.87 |
| Total debt | $1304.69 | $860.96 | $867.07 | $955.48 |
| Total liabilities | $2093.14 | $1844.72 | $1969.88 | $1533.83 |
| Shareholders' equity | ||||
| Retained earnings | $1451.67 | $1241 | $796.95 | $469.56 |
| Other shareholder equity | -$0.42 | -$0.94 | -$0.29 | $0.04 |
| Total shareholder equity | $831.26 | $1043.63 | $1162.03 | $819.68 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $687.51 | $740.68 | $820.88 | $818.27 |
| Cost of revenue | $510.86 | $563.37 | $557.32 | |
| Gross Profit | $213.06 | $229.83 | $257.51 | $260.95 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $149.04 | $174.84 | $185.46 | |
| Total operating expenses | $190.8 | $192.15 | $217.56 | $226.78 |
| Operating income | $37.68 | $39.95 | $34.17 | |
| Income from continuing operations | ||||
| EBIT | $37.68 | $39.95 | $34.17 | |
| Income tax expense | $0.82 | $5.73 | $5.99 | $1.52 |
| Interest expense | -$14.44 | $15.71 | $16.63 | $20.16 |
| Net income | ||||
| Net income | $6.99 | $16.24 | $17.33 | $12.49 |
| Income (for common shares) | $16.24 | $17.33 | $12.49 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3789.25 | $5243.24 | $3984.24 | $2393.71 |
| Cost of revenue | $2539.67 | $3526.56 | $2674.63 | $1601.94 |
| Gross Profit | $1249.58 | $1716.68 | $1309.6 | $791.78 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $756.24 | $936.58 | $730.45 | $549.75 |
| Total operating expenses | $911.15 | $1069.58 | $831.6 | $642.51 |
| Operating income | $338.43 | $647.1 | $478 | $149.26 |
| Income from continuing operations | ||||
| EBIT | $338.43 | $647.1 | $478 | $149.26 |
| Income tax expense | $73.61 | $162.65 | $116.53 | $20.86 |
| Interest expense | $54.14 | $40.4 | $34.08 | $57.74 |
| Net income | ||||
| Net income | $210.68 | $444.05 | $327.39 | $70.67 |
| Income (for common shares) | $210.68 | $444.05 | $327.39 | $70.67 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $16.24 | $17.33 | $12.49 | |
| Operating activities | ||||
| Depreciation | $44.95 | $43.72 | $43.6 | |
| Business acquisitions & disposals | $1.65 | -$292.18 | ||
| Stock-based compensation | $6.36 | $7.74 | $2.58 | |
| Total cash flows from operations | $99.52 | $81.39 | -$41.13 | |
| Investing activities | ||||
| Capital expenditures | -$27.27 | -$18.14 | -$29.86 | |
| Investments | $3.29 | $1.21 | ||
| Total cash flows from investing | -$65.73 | -$22.33 | -$21.4 | -$323.73 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$80 | -$35 | $364.7 | |
| Total cash flows from financing | -$179.55 | -$80.11 | -$38.97 | $363.5 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2.32 | -$2.92 | $21.01 | -$1.37 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $210.68 | $444.05 | $327.39 | $70.67 |
| Operating activities | ||||
| Depreciation | $162.55 | $142.61 | $107.5 | $93.6 |
| Business acquisitions & disposals | -$292.18 | -$69.57 | -$42.69 | -$476.43 |
| Stock-based compensation | $18.02 | $30.07 | $25.22 | $20.46 |
| Total cash flows from operations | $372.17 | $653.73 | $305.36 | $256.83 |
| Investing activities | ||||
| Capital expenditures | -$103.69 | -$75.83 | -$53.57 | -$37.7 |
| Investments | $9.97 | $1.3 | -$3.48 | -$15.47 |
| Total cash flows from investing | -$412.49 | -$170.71 | -$107.4 | -$538.17 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$424.74 | -$576.77 | -$2.69 | |
| Net borrowings | $456.12 | -$21.88 | $229.04 | |
| Total cash flows from financing | $10.73 | -$591.87 | -$34.9 | $211.49 |
| Effect of exchange rate | -$0.34 | -$0.11 | ||
| Change in cash and equivalents | -$29.6 | -$108.84 | $162.72 | -$69.97 |
News
Fundamentals
| Market cap | $804.84M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 38.02M |
| Revenue | $3.07B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $53.04M |
| Revenue Q/Q | -19.44% |
| Revenue Y/Y | -25.12% |
| P/E ratio | 15.17 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.26 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.40 |
|---|---|
| ROA | 1.89% |
| ROE | N/A |
| Debt/Equity | 2.52 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.18 |
| Quick ratio | N/A |